VETORYL 60 MG DIN 02322048
Health Canada record
| Active ingredient(s) | TRILOSTANE 60 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 25-Jun-2009 |
| Current status date | 25-Jun-2009 |
| Source | Health Canada DPD |
Establishment licence of the holder
Dechra Veterinary Products Inc. — licence 102149, currently licensed, last inspection rating C (2025-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRILOSTANE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02322005 | VETORYL 10 MG | DECHRA LTD | Capsule | TRILOSTANE 10 MG | Marketed |
| 02322056 | VETORYL 120 MG | DECHRA LTD | Capsule | TRILOSTANE 120 MG | Marketed |
| 02551276 | VETORYL 20 MG | DECHRA LTD | Capsule | TRILOSTANE 20 MG | Marketed |
| 02322021 | VETORYL 30 MG | DECHRA LTD | Capsule | TRILOSTANE 30 MG | Marketed |
| 02457415 | VETORYL 5 MG | DECHRA LTD | Capsule | TRILOSTANE 5 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 18448 | 2016-09-07 | Supplement to a New Drug Submission (SNDS) | ADDITONAL STRENGTH (5 MG) |
| 10018 | 2009-01-30 | New Drug Submission (NDS) |
International API supply for TRILOSTANE
1 active FDA Drug Master Files.
Request a quote for VETORYL 60 MG